Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis.
Antimicrob Agents Chemother
; 61(8)2017 08.
Article
in En
| MEDLINE
| ID: mdl-28607022
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Pyrazinamide
/
Rifampin
/
Tuberculosis, Pulmonary
/
HIV Infections
/
Tuberculosis, Multidrug-Resistant
/
Ethambutol
/
Isoniazid
/
Antitubercular Agents
Type of study:
Diagnostic_studies
/
Guideline
/
Prognostic_studies
Limits:
Adolescent
/
Adult
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2017
Type:
Article